Medius Holdings Co., Ltd. (3154) AI Stock Analysis

• Market Cap: ¥17.99B
• Dividend Yield: 2.46%
• Average Volume (3M): 18.80K
• Price to Earnings (P/E): 12.8
• Beta (1Y): 0.56
• Revenue Growth: 8.52%
• EPS Growth: 25.85%
• Country: JP
• Employees: 2,517
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 4.88
• Shares Outstanding: 22,238,216
• 10 Day Avg. Volume: 22,330
• 30 Day Avg. Volume: 18,803
• PEG Ratio: 0.66
• Price to Book (P/B): 0.95
• Price to Sales (P/S): 0.07
• P/FCF Ratio: 3.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 67 Neutral
• Price Target: ¥883.00 ▲(8.08% Upside)

Medius Holdings Co., Ltd. shows strong financial performance with revenue growth and profitability improvements, but faces risks from increased leverage and cash flow volatility. The technical analysis indicates a bearish trend, while the valuation suggests the stock may be undervalued. The absence of earnings call and corporate events data limits further insights.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective sales strategies, enhancing long-term business sustainability.

Profitability Improvements

Improved profitability margins suggest better cost management and pricing power, supporting future earnings stability and growth.

Strategic Partnerships

Strategic partnerships expand market reach and enhance product offerings, fostering innovation and competitive advantage.

Negative Factors

Increased Leverage

Higher leverage can increase financial risk and limit flexibility, potentially impacting the company's ability to invest in growth opportunities.

Cash Flow Volatility

Volatile cash flows can challenge the company's ability to fund operations and growth consistently, necessitating better cash management.

Operational Efficiency

Suboptimal operational efficiency may hinder profitability and competitiveness, requiring focus on cost control and process improvements.

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs. The company was formerly known as Kyowa Medical Holdings, Inc. and changed its name to Medius Holdings Co., Ltd. in October 2010. Medius Holdings Co., Ltd. was founded in 2009 and is based in Tokyo, Japan.

How the Company Makes Money

Medius Holdings generates revenue through a combination of software licensing, subscription services, and consulting fees associated with its healthcare technology solutions. The company typically charges clients for initial software licenses, followed by recurring revenue from annual maintenance and subscriptions for ongoing access to their platforms. Additionally, Medius Holdings engages in strategic partnerships with healthcare providers and institutions, allowing them to expand their market reach and enhance their product offerings. These partnerships often lead to joint ventures or collaborative projects that further contribute to the company's earnings.

Medius Holdings Co., Ltd. Financial Statement Overview

Summary

Medius Holdings Co., Ltd. exhibits strong revenue growth and profitability improvements, but increased leverage and cash flow volatility present potential risks. The company should focus on enhancing operational efficiency and stabilizing cash flows to sustain growth.

Income Statement

Medius Holdings Co., Ltd. has demonstrated strong revenue growth with a significant increase of 8.76% in the latest year. The gross profit margin is stable, and the net profit margin has shown improvement. However, the EBIT and EBITDA margins indicate room for improvement in operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has increased, indicating higher leverage, which could pose risks if not managed carefully. However, the return on equity remains positive, reflecting effective use of equity capital. The equity ratio suggests a balanced capital structure.

Cash Flow

The free cash flow has shown significant growth, but the operating cash flow to net income ratio indicates potential volatility in cash generation. The company needs to focus on stabilizing cash flows to support ongoing operations and growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	288.69B	288.69B	259.79B	239.05B	221.69B	246.79B
Gross Profit	33.84B	33.30B	31.09B	29.31B	27.42B	25.20B
EBITDA	4.69B	4.77B	3.86B	4.27B	3.80B	4.14B
Net Income	1.37B	1.38B	1.12B	1.50B	1.87B	2.07B
Balance Sheet
Total Assets	113.02B	113.02B	114.83B	97.46B	92.95B	84.44B
Cash, Cash Equivalents and Short-Term Investments	14.33B	14.33B	13.66B	10.36B	9.15B	12.67B
Total Debt	21.24B	21.24B	24.17B	19.57B	17.82B	11.60B
Total Liabilities	92.55B	92.55B	95.09B	78.88B	75.65B	68.59B
Stockholders Equity	20.48B	20.48B	19.74B	18.57B	17.31B	15.84B
Cash Flow
Free Cash Flow	0.00	5.26B	261.12M	300.65M	-8.49B	2.93B
Operating Cash Flow	0.00	7.01B	1.92B	1.22B	-3.90B	6.85B
Investing Cash Flow	0.00	-2.51B	-2.67B	-862.94M	-4.82B	-4.62B
Financing Cash Flow	0.00	-3.47B	4.01B	862.90M	5.21B	1.90B

Medius Holdings Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 817.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 817 is above the 20-day moving average (MA) of 812.00, above the 50-day MA of 809.70, and below the 200-day MA of 866.25, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 47.36 is Neutral, neither overbought nor oversold. The STOCH value of 58.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7980	75 Outperform	¥5.65B	9.94	―	1.93%	4.41%	-16.07%
4556	69 Neutral	¥5.58B	9.59	―	2.53%	3.14%	-2.85%
7979	69 Neutral	¥66.73B	14.61	―	2.83%	3.69%	1.86%
3154	67 Neutral	¥17.99B	12.76	―	2.46%	8.52%	25.85%
7743	67 Neutral	¥17.65B	12.83	―	2.65%	0.81%	-26.76%
7702	54 Neutral	¥10.97B	70.21	―	3.85%	0.38%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Reports Strong Q1 Performance with Strategic Expansion

Medius Holdings Co., Ltd. reported a 4.4% increase in net sales and a significant 47.1% rise in profit attributable to owners for the first quarter ended September 30, 2025. Despite these positive results, the company experienced a decrease in its equity ratio from 18.1% to 17.1%. The inclusion of REPS Corp. in its consolidation scope marks a strategic expansion, potentially impacting future financial performance.

The most recent analyst rating on (JP:3154) stock is a Hold with a Yen883.00 price target. To see the full list of analyst forecasts on Medius Holdings Co., Ltd. stock, see the JP:3154 Stock Forecast page.